Amir Nashat - Net Worth and Insider Trading
Amir Nashat Net Worth
The estimated net worth of Amir Nashat is at least $268 Million dollars as of 2024-11-13. Amir Nashat is the Director of Morphic Holding Inc and owns about 2,322,946 shares of Morphic Holding Inc (MORF) stock worth over $132 Million. Amir Nashat is the Director of Scholar Rock Holding Corp and owns about 3,754,868 shares of Scholar Rock Holding Corp (SRRK) stock worth over $100 Million. Amir Nashat is also the Director, 10% Owner of Camp4 Therapeutics Corp and owns about 2,625,062 shares of Camp4 Therapeutics Corp (CAMP) stock worth over $31 Million. Besides these, Amir Nashat also holds Fate Therapeutics Inc (FATE) , Cartesian Therapeutics Inc (RNAC) , Syros Pharmaceuticals Inc (SYRS) , Metacrine Inc (MTCR) . Details can be seen in Amir Nashat's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Amir Nashat has not made any transactions after 2024-10-15 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Amir Nashat
Amir Nashat Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Amir Nashat owns 7 companies in total, including aTyr Pharma Inc (ATYR) , Fate Therapeutics Inc (FATE) , and Cartesian Therapeutics Inc (RNAC) among others .
Click here to see the complete history of Amir Nashat’s form 4 insider trades.
Insider Ownership Summary of Amir Nashat
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ATYR | aTyr Pharma Inc | 2015-07-08 | director |
| FATE | Fate Therapeutics Inc | 2019-08-01 | director |
| RNAC | Cartesian Therapeutics Inc | 2019-01-25 | director |
 | | 2016-07-06 | director & 10 percent owner |
| | 2020-09-18 | director & 10 percent owner |
| | 2021-05-21 | director |
| | 2022-06-22 | director |
Amir Nashat Latest Holdings Summary
Amir Nashat currently owns a total of 7 stocks. Among these stocks, Amir Nashat owns 2,322,946 shares of Morphic Holding Inc (MORF) as of July 1, 2019, with a value of $132 Million and a weighting of 49.33%. Amir Nashat owns 3,754,868 shares of Scholar Rock Holding Corp (SRRK) as of June 22, 2022, with a value of $100 Million and a weighting of 37.29%. Amir Nashat also owns 2,625,062 shares of Camp4 Therapeutics Corp (CAMP) as of October 15, 2024, with a value of $31 Million and a weighting of 11.65%. The other 4 stocks Fate Therapeutics Inc (FATE) , Cartesian Therapeutics Inc (RNAC) , Syros Pharmaceuticals Inc (SYRS) , Metacrine Inc (MTCR) have a combined weighting of 1.74% among all his current holdings.
Latest Holdings of Amir Nashat
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| MORF | Morphic Holding Inc | 2019-07-01 | 2,322,946 | 56.99 | 132,384,693 |
| SRRK | Scholar Rock Holding Corp | 2022-06-22 | 3,754,868 | 26.65 | 100,067,232 |
| CAMP | Camp4 Therapeutics Corp | 2024-10-15 | 2,625,062 | 11.91 | 31,251,363 |
| FATE | Fate Therapeutics Inc | 2019-08-01 | 1,139,783 | 2.38 | 2,712,684 |
| RNAC | Cartesian Therapeutics Inc | 2019-01-25 | 89,208 | 16.93 | 1,510,291 |
| SYRS | Syros Pharmaceuticals Inc | 2016-07-06 | 158,665 | 2.73 | 433,155 |
| MTCR | Metacrine Inc | 2020-09-18 | 178,942 | 0.00 | 251 |
Holding Weightings of Amir Nashat
Amir Nashat Form 4 Trading Tracker
According to the SEC Form 4 filings, Amir Nashat has made a total of 0 transactions in Morphic Holding Inc (MORF) over the past 5 years. The most-recent trade in Morphic Holding Inc is the acquisition of 125,000 shares on July 1, 2019, which cost Amir Nashat around $2 Million.
According to the SEC Form 4 filings, Amir Nashat has made a total of 1 transactions in Scholar Rock Holding Corp (SRRK) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Scholar Rock Holding Corp is the acquisition of 1,197,992 shares on June 22, 2022, which cost Amir Nashat around $6 Million.
According to the SEC Form 4 filings, Amir Nashat has made a total of 1 transactions in Camp4 Therapeutics Corp (CAMP) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Camp4 Therapeutics Corp is the acquisition of 909,090 shares on October 15, 2024, which cost Amir Nashat around $10 Million.
More details on Amir Nashat's insider transactions can be found in the Insider Trading History of Amir Nashat table.Insider Trading History of Amir Nashat
- 1
Amir Nashat Trading Performance
GuruFocus tracks the stock performance after each of Amir Nashat's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Amir Nashat is 4.12%. GuruFocus also compares Amir Nashat's trading performance to market benchmark return within the same time period. The performance of stocks bought by Amir Nashat within 3 months outperforms 4 times out of 8 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Amir Nashat's insider trading performs compared to the benchmark.
Performance of Amir Nashat
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 1.16 | | | | | |
| Relative Return to S&P 500(%) | -2.94 | | | | | |
Amir Nashat Ownership Network
Ownership Network List of Amir Nashat
Ownership Network Relation of Amir Nashat
Amir Nashat Owned Company Details
What does aTyr Pharma Inc do?
Who are the key executives at aTyr Pharma Inc?
Amir Nashat is the director of aTyr Pharma Inc. Other key executives at aTyr Pharma Inc include Chief Financial Officer Jill Marie Broadfoot , Chief Medical Officer Sanjay Shukla , and See Remarks Nancy Krueger .
aTyr Pharma Inc (ATYR) Insider Trades Summary
Over the past 18 months, Amir Nashat made no insider transaction in aTyr Pharma Inc (ATYR). Other recent insider transactions involving aTyr Pharma Inc (ATYR) include a net purchase of 65,000 shares made by Sanjay Shukla , a net purchase of 3,410 shares made by Jill Marie Broadfoot , and a net purchase of 100,000 shares made by Paul Schimmel .
In summary, during the past 3 months, insiders sold 0 shares of aTyr Pharma Inc (ATYR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 1,590 shares of aTyr Pharma Inc (ATYR) were sold and 225,000 shares were bought by its insiders, resulting in a net purchase of 223,410 shares.
aTyr Pharma Inc (ATYR)'s detailed insider trading history can be found in Insider Trading Tracker table.
aTyr Pharma Inc Insider Transactions
Amir Nashat Mailing Address
Above is the net worth, insider trading, and ownership report for Amir Nashat. You might contact Amir Nashat via mailing address: 10835 Road To The Cure, Suite 205, San Diego Ca 92121.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
